News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
38,203 Results
Type
Article (2437)
Company Profile (39)
Press Release (35727)
Multimedia
Podcasts (4)
Webinars (2)
Section
Business (14121)
Career Advice (77)
Deals (2077)
Drug Delivery (9)
Drug Development (4101)
Employer Resources (10)
FDA (431)
Job Trends (763)
News (20138)
Policy (1053)
Tag
2024 BioForest Digital (4)
2024 BioMidwest Digital (2)
2024 Biotech Bay Standard (2)
2024 Biotech Beach Digital (1)
2024 Biotech Beach Standard (1)
2024 Lone Star Bio Digital (1)
2024 Pharm Country Digital (1)
2025 Lone Star Bio Digital (1)
Academia (144)
Allergies (6)
Alliances (3474)
ALS (4)
Alzheimer's disease (45)
Antibody-drug conjugate (ADC) (14)
Approvals (432)
Artificial intelligence (11)
Autoimmune disease (3)
Automation (1)
Bankruptcy (12)
Best Places to Work (475)
BIOSECURE Act (2)
Biosimilars (12)
Biotechnology (29)
Bladder cancer (6)
Brain cancer (5)
Breast cancer (19)
Cancer (138)
Cardiovascular disease (5)
Career advice (64)
Career pathing (1)
CAR-T (15)
Cell therapy (43)
Cervical cancer (2)
Clinical research (3176)
Collaboration (94)
Compensation (48)
COVID-19 (180)
CRISPR (7)
C-suite (27)
Cystic fibrosis (2)
Data (112)
Denatured (3)
Depression (3)
Diabetes (10)
Diagnostics (467)
Digital health (1)
Diversity, equity & inclusion (1)
Drug discovery (15)
Drug pricing (7)
Duchenne muscular dystrophy (12)
Earnings (4235)
Editorial (3)
Employer branding (1)
Employer resources (8)
Events (6028)
Executive appointments (96)
FDA (477)
Featured Employer (3)
Funding (77)
Gene editing (14)
Gene therapy (18)
GLP-1 (60)
Government (149)
Healthcare (705)
Huntington's disease (3)
IgA nephropathy (3)
Immunology and inflammation (16)
Indications (2)
Infectious disease (185)
Inflammatory bowel disease (11)
Inflation Reduction Act (6)
Influenza (4)
Intellectual property (10)
Interviews (7)
IPO (987)
IRA (7)
Job creations (290)
Job search strategy (62)
Kidney cancer (4)
Labor market (4)
Layoffs (37)
Leadership (1)
Legal (212)
Liver cancer (5)
Lung cancer (15)
Lymphoma (3)
Management (4)
Manufacturing (19)
MASH (4)
Medical device (307)
Medtech (307)
Mergers & acquisitions (1159)
Metabolic disorders (34)
Multiple sclerosis (7)
Neurodegenerative disease (9)
Neuropsychiatric disorders (3)
Neuroscience (90)
NextGen: Class of 2025 (352)
Non-profit (153)
Northern California (359)
Now hiring (4)
Obesity (16)
Opinion (15)
Ovarian cancer (10)
Pain (9)
Pancreatic cancer (3)
Parkinson's disease (4)
Partnered (2)
Patents (22)
Patient recruitment (4)
Peanut (1)
People (5660)
Pharmaceutical (5)
Phase I (1372)
Phase II (1591)
Phase III (847)
Pipeline (74)
Policy (12)
Postmarket research (30)
Preclinical (593)
Press Release (2)
Prostate cancer (3)
Psychedelics (2)
Radiopharmaceuticals (12)
Rare diseases (22)
Real estate (420)
Recruiting (5)
Regulatory (804)
Reports (6)
Research institute (142)
Resumes & cover letters (9)
Schizophrenia (10)
Series A (25)
Series B (5)
Service/supplier (2)
Sickle cell disease (1)
Southern California (354)
Special edition (1)
Spinal muscular atrophy (2)
Sponsored (1)
Startups (489)
Stomach cancer (1)
Supply chain (4)
The Weekly (1)
United States (1725)
Vaccines (28)
Venture capitalists (8)
Weight loss (12)
Women's health (1)
Worklife (1)
Date
Today (4)
Last 7 days (38)
Last 30 days (205)
Last 365 days (2554)
2025 (746)
2024 (2610)
2023 (2858)
2022 (3752)
2021 (4048)
2020 (3471)
2019 (2061)
2018 (1565)
2017 (1799)
2016 (1624)
2015 (1834)
2014 (1369)
2013 (1188)
2012 (1396)
2011 (1332)
2010 (1181)
Location
Africa (43)
Alabama (1)
Arizona (14)
Asia (1862)
Australia (298)
California (827)
Canada (132)
China (38)
Colorado (20)
Connecticut (10)
Delaware (4)
Europe (3817)
Florida (44)
Georgia (5)
Idaho (3)
Illinois (14)
India (1)
Indiana (32)
Japan (7)
Kansas (12)
Maryland (25)
Massachusetts (302)
Michigan (8)
Minnesota (14)
Missouri (3)
Nebraska (1)
Nevada (3)
New Hampshire (2)
New Jersey (69)
New York (49)
North Carolina (90)
Northern California (359)
Ohio (25)
Oklahoma (2)
Oregon (4)
Pennsylvania (49)
Rhode Island (2)
South America (40)
South Carolina (1)
Southern California (354)
Tennessee (2)
Texas (71)
Utah (2)
Virginia (6)
Washington D.C. (1)
Washington State (50)
Wisconsin (6)
38,203 Results for "anixa biosciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Anixa Biosciences Receives Notice of Allowance from USPTO for Ovarian Cancer Vaccine
March 24, 2025
·
3 min read
Press Releases
Anixa Biosciences to Present at the Jones Las Vegas Healthcare and Technology Innovation Conference on April 9th
April 1, 2025
·
3 min read
Press Releases
Anixa Biosciences CEO to Present at the 2025 CAGLA NeauxCancer Conference on March 28th
March 17, 2025
·
3 min read
Press Releases
Anixa Biosciences CEO Provides Letter to Shareholders
January 21, 2025
·
6 min read
Press Releases
Anixa Biosciences’ Breast Cancer Vaccine was Featured on Fox News’ “America Reports”
February 25, 2025
·
4 min read
Press Releases
Anixa Biosciences Receives Notice of Allowance from U.S. Patent and Trademark Office for Patent Covering Breast Cancer Vaccine Technology
April 9, 2025
·
3 min read
Press Releases
Anixa Biosciences 2025 Annual Meeting of Stockholders to Include Investor Presentation Open to All Interested Parties
March 10, 2025
·
3 min read
Press Releases
Anixa Biosciences Receives Notice of Allowance from U.S. Patent and Trademark Office for CAR-T Technology, Further Strengthening its Robust Intellectual Property Portfolio
April 14, 2025
·
3 min read
Press Releases
Anixa Biosciences Enters Letter of Intent with VERDI Solutions to Develop Artificial Intelligence-Guided Personalized and Off-the-Shelf Cancer Vaccines
March 26, 2025
·
6 min read
Press Releases
Anixa Biosciences to Present at the 18th Annual European Life Sciences CEO Forum
February 11, 2025
·
3 min read
1 of 3,821
Next
